Form 4: Edwards Lifesciences Executive Sells Shares
Insider Transaction (Form 4)
Andrew M. Dahl, SVP, Corporate Controller of Edwards Lifesciences Corp, sold 544 shares of common stock on August 31, 2026 for $91.06 per share.
Summary
- Open-market sale: disposed of 544 Common Stock at $91.06 ($49,534) on August 31, 2026; holds 14,868 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $49,534 of stock on the open market.
Insider Transactions
Andrew M. Dahl — Officer (SVP, Corporate Controller)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Open-market sale | Common Stock | 544 | $91 | $49.5K | 14,868.41 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Open-market sale (544 shares) |
Keywords
insider transaction, Form 4, EW, Edwards Lifesciences Corp, bearish, Andrew M. Dahl
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.